Pierconti Francesco, Martini Maurizio, Cenci Tonia, Petrone Gian Luigi, Ricci Riccardo, Sacco Emilio, Bassi Pier Francesco, Larocca Luigi Maria
Department of Pathology, Catholic University of Sacred Heart, Rome, Italy.
Department of Urology, Catholic University of Sacred Heart, Rome, Italy.
Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.
In the 2014, The International Society of Urological Pathology (ISUP) consensus conference update the grading of prostate, last revised in 2005. In this study we evaluate the SOCS3 immunohistochemical protein expression in different Gleason prostatic adenocarcinoma: classical Gleason grade 3, classical Gleason grade 3 upgraded to Gleason grade 4 according to the ISUP modifications and classical and modified Gleason grade 4. The major conclusions were: (i) Cribriform glands should be assigned a Gleason pattern 4, regardless of morphology; (ii) Glomeruloid glands should be assigned a Gleason pattern 4, regardless of morphology; (iii) Grading of mucinous carcinoma of the prostate should be based on its underlying growth pattern rather than all as pattern 4; and (iv) Intraductal carcinoma of the prostate without invasive carcinoma should not assigned Gleason grade and a comment about aggressive carcinoma probably associated should be made. In a recent report we analyzed the methylathion status of cytokine signaling (SOCS) proteins 3 (SOCS3) gene and the consequences of promoter hypermethylation on mRNA and protein expression in a collection of prostate cancer and benign prostate hyperplasia (BPH) and for the first time we demonstrated that a hypermethylation of SOCS3 with a significant reduction of its mRNA and protein expression identifies a subgroup of prostate cancer with a more aggressive behavior. Moreover we demonstrated that the immunohystochemical analysis of SOCS3 protein expression in prostatic cancer biopsies may provide a useful and easier method than SOCS3 methylation analysis to individuate in cancer with intermediate-high grade Gleason score a subgroup of prostate cancer with a more aggressive behavior.
A total of 148 radical prostatectomy with diagnosis of prostatic acinar adenocarcinoma were stratified into three different categories on the basis of Gleason grade: (i) Twenty-six prostatic adenocarcinoma with classical and modified Gleason grade 3; (ii) Fifty seven prostatic adenocarcinoma with classical Gleason grade 3 upgraded to Gleason grade 4 by 2005 and 2014 ISUP Consensus Conference; and (iii) Sixty five prostatic adenocarcinoma with classical and modified Gleason grade 4. Immunohistochemical analysis for SOCS3 was performed and SOCS3 staining intensity were evaluated by two pathologists in three different ways on the basis of the intensity of cytoplasmatic staining: positive (intense cytoplasmatic staining in more than 50% of neoplastic cells) (+), negative (absence of cytoplasmatic staining in more than 50% of neoplastic cells) (-), weakly positive (weak cytoplasmatic staining in more than 50% of neoplastic cells (+/-).
In the group of prostatic adenocarcinoma Gleason grade 3 we found that SOCS3 positivity (+) were observed in 19 out of 26 cases (73.1%); in 5 out of 26 prostatic adenocarcinoma the neoplastic glands showed weak intensity SOCS3 staining (+/-) (19.2%), while in only two cases we found SOCS-3 negativity (-) (7.7%); in the group of cases with prostatic adenocarcinoma with Gleason grade 4, 16 out 65 cases (24.6%) showed SOCS3 positivity (+); 18 out 65 cases (27.7%) SOCS3 weakly positive (+/-), and in 31 cases (47.7%) SOCS3 negative staining (-) were observed. Interestingly, the group of prostatic adenocarcinoma with histological Gleason 3 pattern upgraded to Gleason 4 pattern according to the 2005 and 2014 ISUP modified grading system, showed SOCS3 positivity (+) in 16 out of 57 cases (28%), in 16 out 57 cases (28%) a weakly positive for SOCS3 (+/-) were observed, while 25 cases (44%) showed negative SOCS3 staining (-).
In this study we demonstrated a significant association of SOCS3 positivity (+) with prostatic carcinoma classical Gleason pattern 3 (P < 0.0001), while SOCS3 negative pattern (-) or SOCS3 weakly positive pattern (+/-) were associated to prostatic carcinomas with Gleason pattern 3 upgraded to Gleason pattern 4 (P = 0.0002) and with classical Gleason pattern 4. The significant difference of SOCS3 immunohistochemical expression between classical Gleason grade 3 and Gleason grade 4 upgraded to grade 4 seems to support the definitions and the modifications of Gleason grade 4 of the 2005 and the 2014 International Society of Urological Pathology (ISUP). The hypoexpression of SOCS3 protein in glomeruloid glands could support the hypothesis that from molecular point of view this growth pattern could be different from classical Gleason pattern 3 and biologically more closely to Gleason pattern 4, confirming the conclusions of the 2014 ISUP Conference assigning a Gleason pattern 4 to glomeruloid glands regardless of morphology. Prostate 77: 597-603, 2017. © 2017 Wiley Periodicals, Inc.
2014年,国际泌尿病理学会(ISUP)共识会议更新了前列腺癌分级,上次修订是在2005年。在本研究中,我们评估了细胞因子信号转导抑制因子3(SOCS3)在不同Gleason分级前列腺腺癌中的免疫组化蛋白表达情况:经典Gleason 3级、根据ISUP修订标准从经典Gleason 3级升级为Gleason 4级以及经典和修订后的Gleason 4级。主要结论如下:(i)筛状腺体应归为Gleason 4级,无论其形态如何;(ii)肾小球样腺体应归为Gleason 4级,无论其形态如何;(iii)前列腺黏液腺癌的分级应基于其潜在生长模式,而非全部归为4级;(iv)无浸润性癌的前列腺导管内癌不应给予Gleason分级,应说明可能与之相关的侵袭性癌。在最近的一份报告中,我们分析了细胞因子信号转导抑制因子(SOCS)蛋白3(SOCS3)基因的甲基化状态以及启动子高甲基化对一组前列腺癌和良性前列腺增生(BPH)中mRNA和蛋白表达的影响,并且首次证明SOCS3的高甲基化及其mRNA和蛋白表达的显著降低可识别出具有更侵袭性行为的前列腺癌亚组。此外,我们还证明,与SOCS3甲基化分析相比,前列腺癌活检中SOCS3蛋白表达的免疫组化分析可能是一种更有用、更简便的方法,可用于在中高分级Gleason评分的癌症中识别出具有更侵袭性行为的前列腺癌亚组。
对148例诊断为前列腺腺泡腺癌的根治性前列腺切除术病例,根据Gleason分级分为三类:(i)26例经典和修订后Gleason 3级前列腺腺癌;(ii)57例经2005年和2014年ISUP共识会议从经典Gleason 3级升级为Gleason 4级的前列腺腺癌;(iii)65例经典和修订后Gleason 4级前列腺腺癌。进行了SOCS3免疫组化分析,两名病理学家根据细胞质染色强度以三种不同方式评估SOCS3染色强度:阳性(超过50%的肿瘤细胞细胞质染色强烈)(+)、阴性(超过50%的肿瘤细胞无细胞质染色)(-)、弱阳性(超过50%的肿瘤细胞细胞质染色微弱)(+/-)。
在Gleason 3级前列腺腺癌组中,我们发现26例中有19例(73.1%)观察到SOCS3阳性(+);26例前列腺腺癌中有5例肿瘤腺体显示SOCS3弱阳性(+/-)(19.2%),而仅2例发现SOCS-3阴性(-)(7.7%);在Gleason 4级前列腺腺癌组中,65例中有16例(24.6%)显示SOCS3阳性(+);65例中有18例(27.7%)SOCS3弱阳性(+/-),31例(47.7%)观察到SOCS3阴性染色(-)。有趣的是,根据2005年和2014年ISUP修订分级系统从组织学Gleason 3级升级为Gleason 4级的前列腺腺癌组中,57例中有16例(28%)显示SOCS3阳性(+),57例中有16例(28%)观察到SOCS3弱阳性(+/-),而25例(44%)显示SOCS3阴性染色(-)。
在本研究中,我们证明SOCS3阳性(+)与经典Gleason 3级前列腺癌显著相关(P<0.0001),而SOCS3阴性模式(-)或SOCS3弱阳性模式(+/-)与从Gleason 3级升级为Gleason 4级以及经典Gleason 4级的前列腺癌相关(P = 0.0002)。经典Gleason 3级和升级为4级的Gleason 4级之间SOCS3免疫组化表达的显著差异似乎支持2005年和2014年国际泌尿病理学会(ISUP)对Gleason 4级的定义和修订。肾小球样腺体中SOCS3蛋白的低表达可能支持这样的假设,即从分子角度来看,这种生长模式可能与经典Gleason 3级不同,在生物学上更接近Gleason 4级,这证实了2014年ISUP会议的结论,即无论形态如何,肾小球样腺体应归为Gleason 4级。《前列腺》77: 597 - 603, 2017。© 2017威利期刊公司。